How have XSNX shares performed in 2024?

NovAccess Global's stock was trading at $0.0201 at the start of the year. Since then, XSNX stock has decreased by 60.2% and is now trading at $0.0080. View the best growth stocks for 2024 here .

Are investors shorting NovAccess Global?

NovAccess Global saw a increase in short interest in March. As of March 31st, there was short interest totaling 65,900 shares, an increase of 16,375.0% from the March 15th total of 400 shares. Based on an average daily trading volume, of 621,800 shares, the short-interest ratio is currently 0.1 days. View NovAccess Global's Short Interest .

How were NovAccess Global's earnings last quarter?

NovAccess Global Inc. (OTCMKTS:XSNX) issued its quarterly earnings data on Tuesday, February, 27th. The company reported $0.01 earnings per share (EPS) for the quarter.

What other stocks do shareholders of NovAccess Global own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NovAccess Global investors own include Co-Diagnostics (CODX) , iBio (IBIO) , SANUWAVE Health (SNWV) , Sierra Oncology (SRRA) , Tonix Pharmaceuticals (TNXP) , T2 Biosystems (TTOO) , Kopin (KOPN) , Ascent Solar Technologies (ASTI) and BioRestorative Therapies (BRTX) .

How do I buy shares of NovAccess Global?

Shares of XSNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:XSNX

NovAccess Global (XSNX) Stock Price, News & Analysis

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Free XSNX Stock Alerts

$0.0080

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.0074
▼
$0.0087
50-Day Range: $0.01
▼
$0.03
52-Week Range: $0.01
▼
$0.22

Volume: 1.06 million shs
Average Volume: 470,538 shs
Market Capitalization: $280,000.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials Headlines SEC Filings Short Interest

Get NovAccess Global alerts:

Ad InvestorPlace

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About NovAccess Global Stock (OTCMKTS:XSNX)

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.

XSNX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

XSNX Stock News Headlines

April 11, 2024 | americanbankingnews.com

NovAccess Global Inc. (OTCMKTS:XSNX) Short Interest Up 16,375.0% in March

February 7, 2024 | msn.com

NovAccess Global Faces Default and Uncertain Rescue Deal

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

January 2, 2024 | msn.com

NovAccess Global jumps on announcing $10.7 million financing

January 2, 2024 | finanznachrichten.de

NovAccess Global Inc.: NovAccess Global Announces $10.7 Million Financing

January 2, 2024 | finance.yahoo.com

NovAccess Global Announces $10.7 Million Financing

December 1, 2023 | finance.yahoo.com

NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit

November 10, 2023 | finance.yahoo.com

NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board

April 19, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

November 2, 2023 | morningstar.com

Novaccess Global Inc XSNX

July 29, 2023 | finanznachrichten.de

NovAccess Global Inc.: NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform

July 27, 2023 | finance.yahoo.com

NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform

July 13, 2023 | finance.yahoo.com

NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day

July 6, 2023 | finance.yahoo.com

XSNX - NovAccess Global Inc.

June 16, 2023 | finanznachrichten.de

NovAccess Global Inc.: NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division

June 16, 2023 | finance.yahoo.com

NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division

June 1, 2023 | finance.yahoo.com

NovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies

May 11, 2023 | finanznachrichten.de

NovAccess Global Inc.: NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements

May 11, 2023 | finance.yahoo.com

NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements

March 15, 2023 | finanznachrichten.de

NovAccess Global Inc.: Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award

March 15, 2023 | finance.yahoo.com

Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award

February 16, 2023 | finanznachrichten.de

NovAccess Global Inc.: NovAccess Global to Present at World Orphan Drug Congress

February 16, 2023 | finance.yahoo.com

NovAccess Global to Present at World Orphan Drug Congress

February 3, 2023 | finanznachrichten.de

NovAccess Global Inc.: NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress

February 3, 2023 | finance.yahoo.com

NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress

January 5, 2023 | finance.yahoo.com

NovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company’s Lead Scientist and President of its StemVax Therapeutics Division

November 22, 2022 | finanznachrichten.de

NovAccess Global Inc.: NovAccess Global Announces Initial Fireside Chat with Glioblastoma Patient Advocate

See More Headlines

Receive XSNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NovAccess Global and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/27/2024
Today: 4/19/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:XSNX
CUSIP: N/A
CIK: 1039466
Web: www.xsunx.com
Phone: (213) 642-9268
Fax: 949-266-5823
Employees: 3
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.10)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-4,720,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -877.60%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.58) per share
Price / Book: -0.01

Miscellaneous

Outstanding Shares: 35,000,000
Free Float: 34,493,000
Market Cap: $280,000.00
Optionable: Not Optionable
Beta: 1.51

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Dr. Dwain K. Morris-Irvin M.P.H. (Age 56)
MPH, Ph.D., CEO & Director
Comp: $155.43k
Mr. Neil J. Laird (Age 71)
Chief Financial Officer
Dr. Christopher Wheeler Ph.D.
President of Stemvax Therapeutics

Key Competitors

View All Competitors

XSNX Stock Analysis - Frequently Asked Questions

How have XSNX shares performed in 2024?: NovAccess Global's stock was trading at $0.0201 at the start of the year. Since then, XSNX stock has decreased by 60.2% and is now trading at $0.0080.
View the best growth stocks for 2024 here.
Are investors shorting NovAccess Global?: NovAccess Global saw a increase in short interest in March. As of March 31st, there was short interest totaling 65,900 shares, an increase of 16,375.0% from the March 15th total of 400 shares. Based on an average daily trading volume, of 621,800 shares, the short-interest ratio is currently 0.1 days.
View NovAccess Global's Short Interest.
How were NovAccess Global's earnings last quarter?: NovAccess Global Inc. (OTCMKTS:XSNX) issued its quarterly earnings data on Tuesday, February, 27th. The company reported $0.01 earnings per share (EPS) for the quarter.

What other stocks do shareholders of NovAccess Global own?: Based on aggregate information from My MarketBeat watchlists, some companies that other NovAccess Global investors own include Co-Diagnostics (CODX), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN), Ascent Solar Technologies (ASTI) and BioRestorative Therapies (BRTX).
How do I buy shares of NovAccess Global?: Shares of XSNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:XSNX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial